This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

IQVIA Holdings Past Earnings Performance

Past criteria checks 5/6

IQVIA Holdings has been growing earnings at an average annual rate of 5.2%, while the Life Sciences industry saw earnings growing at 27.3% annually. Revenues have been growing at an average rate of 8.6% per year. IQVIA Holdings's return on equity is 22.1%, and it has net margins of 8.3%.

Key information

5.2%

Earnings growth rate

9.0%

EPS growth rate

Life Sciences Industry Growth26.8%
Revenue growth rate8.6%
Return on equity22.1%
Net Margin8.3%
Last Earnings Update30 Sep 2022

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How IQVIA Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XTRA:QTS Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2214,3071,1821,9970
30 Jun 2214,1361,1601,9780
31 Mar 2214,0331,0791,9770
31 Dec 2113,8749661,9310
30 Sep 2113,5367671,8860
30 Jun 2112,9316071,8480
31 Mar 2112,0144091,7970
31 Dec 2011,3592791,7620
30 Sep 2010,9561761,7590
30 Jun 2010,9391321,6940
31 Mar 2011,1582151,6990
31 Dec 1911,0881911,7110
30 Sep 1910,8812441,6690
30 Jun 1910,7062471,7030
31 Mar 1910,5332481,6910
31 Dec 1810,4122591,6920
30 Sep 1810,2451,2171,7380
30 Jun 1810,1171,2451,6990
31 Mar 189,9051,2461,6440
31 Dec 179,7021,2771,6050
30 Sep 179,133721,5280
30 Jun 177,804841,3450
31 Mar 176,6161081,1920
31 Dec 166,815721,0130
30 Sep 164,5403977610
30 Jun 164,4974097850
31 Mar 164,4044087950
31 Dec 154,3263878150

Quality Earnings: QTS has high quality earnings.

Growing Profit Margin: QTS's current net profit margins (8.3%) are higher than last year (5.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: QTS's earnings have grown by 5.2% per year over the past 5 years.

Accelerating Growth: QTS's earnings growth over the past year (54.1%) exceeds its 5-year average (5.2% per year).

Earnings vs Industry: QTS earnings growth over the past year (54.1%) exceeded the Life Sciences industry 12.2%.


Return on Equity

High ROE: Whilst QTS's Return on Equity (22.11%) is high, this metric is skewed due to their high level of debt.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/11/16 10:14
End of Day Share Price 2022/08/19 00:00
Earnings2022/09/30
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

IQVIA Holdings Inc. is covered by 40 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jasper HellwegArgus Research Company
Gregory BolanAvondale Partners
Eric ColdwellBaird